EUVIMEDEUVIMED entdecken
Crossref

TRANSCORNEAL PERMEATION ENHANCEMENT OF MOXIFLOXACIN USING AMINO ACID CO-EVAPORATED SYSTEMS

PUNIT SHARMA

International Journal of Pharmacological and Pharmaceutical Innovations (IJPPI) · 2026

DOI: 10.67540/ijppi.v1.i3.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmacological and Pharmaceutical Innovations (IJPPI), 2026. Verfasst von PUNIT SHARMA. Die Arbeit nennt 19 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Drug delivery to the eye continues to be challenging because of its natural protective barriers, which limit drug absorption. Conventional topical formulations traditional ocular dosage forms, such as eye drops, show limited bioavailability owing to rapid tear clearance and dilution in the precorneal area.

Objective

This study aimed to investigate whether co-processing moxifloxacin with selected amino acids (alanine, glycine, leucine and lysine) by solvent evaporation could enhance ex vivo transcorneal permeation across isolated goat cornea.

Methods

Moxifloxacin was co-processed with alanine, glycine, leucine and lysine in equimolar proportions by dissolution in ethanol followed by solvent evaporation and desiccation. Because covalent bond formation was not confirmed by structural techniques such as NMR or mass spectrometry, these products are described as amino acid co-evaporated systems rather than confirmed chemical conjugates. Ophthalmic solutions were prepared using EDTA or methyl paraben and methylcellulose or HPMC. Ex vivo transcorneal permeation studies were performed across isolated goat cornea using a modified Franz diffusion cell, while corneal hydration was assessed to verify tissue integrity.

Results

Moxifloxacin was hydrophilic (log P = 0.14). Among the tested systems, the moxifloxacin–lysine co-evaporated system showed the highest 120-min permeation (8.26±0.09%) while maintaining corneal hydration within the accepted physiological range. The corresponding eye-drop formulations also showed higher ex vivo permeation than conventional moxifloxacin formulations and the marketed comparator. These findings demonstrate enhanced ex vivo transcorneal permeation but do not establish in vivo ocular bioavailability.

Conclusion

Co-processing moxifloxacin with lysine by solvent evaporation was associated with improved ex vivo transcorneal permeation compared with moxifloxacin alone. Further structural characterization, transporter-inhibition studies, sterility testing and in vivo investigations are required before chemical conjugation, transporter-mediated uptake or improved ocular bioavailability can be confirmed.

Zitieren

APA

SHARMA, P. (2026). TRANSCORNEAL PERMEATION ENHANCEMENT OF MOXIFLOXACIN USING AMINO ACID CO-EVAPORATED SYSTEMS. International Journal of Pharmacological and Pharmaceutical Innovations (IJPPI). https://doi.org/10.67540/ijppi.v1.i3.028

Vancouver

SHARMA P. TRANSCORNEAL PERMEATION ENHANCEMENT OF MOXIFLOXACIN USING AMINO ACID CO-EVAPORATED SYSTEMS. International Journal of Pharmacological and Pharmaceutical Innovations (IJPPI). 2026. doi:10.67540/ijppi.v1.i3.028

BibTeX
@article{SHARMA2026,
  author = {SHARMA, PUNIT},
  title = {TRANSCORNEAL PERMEATION ENHANCEMENT OF MOXIFLOXACIN USING AMINO ACID CO-EVAPORATED SYSTEMS},
  journal = {International Journal of Pharmacological and Pharmaceutical Innovations (IJPPI)},
  year = {2026},
  doi = {10.67540/ijppi.v1.i3.028}
}
Kostenlos starten →